Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Damora Therapeutics, Inc. is a biotechnology company that focuses on hematologic disorders. It is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms (MPN), including essential thrombocythemia and myelofibrosis, where there is significant medical need for disease-modifying treatments. Its lead asset, DMR-001, is an investigational monoclonal antibody therapy targeting mutant calreticulin (mutCALR). It is developing candidates for treatment of essential thrombocythemia (ET), an MPN associated with the overproduction of platelets, and myelofibrosis, an MPN involving the overproliferation of blood cells and deposition of fibrous material in the bone marrow and spleen. DMR-002, an afucosylated antibody designed to enhance antibody-dependent cellular cytotoxicity and amplify natural immune killing of malignant cells. DMR-003, a bi-specific T-cell engager antibody designed to recruit and direct T-cell-mediated killing of malignant cells.
Find out what a historical investment in Damora Therapeutics Inc would be worth today using our DMRA stock calculator.
Buying DMRA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Damora Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in DMRA
What is the ticker symbol of Damora Therapeutics Inc?
The ticker symbol for Damora Therapeutics Inc is DMRA.
How much is one share of DMRA?
One share of DMRA is valued at $24.30 as of 20 November 2026.
What is the market capitalisation of Damora Therapeutics Inc DMRA?
As of 20 November 2026 Damora Therapeutics Inc has a market cap of $1.42B.
What is the 52-week high for Damora Therapeutics Inc stock?
The Damora Therapeutics Inc 52-week high stock price is $38.33.
What is the 52-week low for Damora Therapeutics Inc stock?
The Damora Therapeutics Inc 52-week low stock price is $15.76.
Can I buy DMRA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DMRA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DMRA on Stake
Buy DMRA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of DMRA from only US$10 with fractional shares